IP Library Granted Patent US 12,023,459
Granted Patent B2
US 12,023,459 · App. 17/392,165 · Granted Jul 2, 2024

Negative pressure therapy system

Inventors: John R. Erbey, II (Milton, GA); Jacob L. Upperco (Atlanta, GA); Michael Alan Fisher (Lawrenceville, GA); Patrick William Strane (Atlanta, GA); Lance Michael Black (Pearland, TX)
Assignee: Roivios Limited
A61M27/008A61M1/70A61M1/73A61M1/743A61M1/80A61M1/84A61M25/0017A61M25/0023A61M25/0026A61M25/04A61M25/10A61M25/1025A61M39/12A61F2013/15146A61F13/2002A61M25/0068A61M25/0074A61M2025/0213A61M2202/0496A61M2205/0266A61M2205/3303A61M2205/3368A61M2205/50A61M2205/52A61M2205/75A61M2210/1085A61M2210/1092A61M2210/1096A61M2230/20A61M2230/50A61M2230/65
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,023,459
App. No.
17/392,165
Granted
Jul 2, 2024
Kind
B2
Abstract

Negative pressure therapy systems are provided for increasing urine production, the negative pressure therapy system including: (a) a pump assembly, the pump assembly including: (i) a pump configured to provide negative pressure to a kidney, and (ii) a controller configured to regulate the negative pressure provided by the pump within a pressure range that facilitates increased urine production from the kidney.

Claims (27)

1. A negative pressure therapy system for increasing urine production, the negative pressure therapy system comprising:

(a) a pump assembly, the pump assembly comprising:

(i) a pump configured to provide negative pressure to a kidney, and

(ii) a controller configured to regulate the negative pressure provided by the pump within a pressure range of about 5 mm Hg to about 25 mm Hg to increase urine output from the kidney.

2. The negative pressure therapy system of claim 1 , wherein the controller regulates the negative pressure provided by the pump based upon changes in physiological condition.

3. The negative pressure therapy system of claim 2 , further comprising one or more sensors that detect change(s) in the physiological condition, wherein the controller regulates the negative pressure provided by the pump based upon information measured by the one or more sensors.

4. The negative pressure therapy system of claim 1 , wherein the controller is integrated into the pump.

5. The negative pressure therapy system of claim 1 , wherein the controller is located outside of a body.

6. The negative pressure therapy system of claim 1 , wherein the pump is located outside of a body.

7. The negative pressure therapy system of claim 1 , further comprising a catheter having (i) a proximal portion comprising a drainage lumen and (ii) a distal portion comprising a retention portion configured to be positioned in a urinary tract, the retention portion comprising one or more drainage ports that permit fluid flow into the drainage lumen.

8. The negative pressure therapy system of claim 7 , wherein the proximal portion of the catheter is configured to be connected to the pump to provide negative pressure through the catheter to the kidney.

9. The negative pressure therapy system of claim 8 , wherein the retention portion is configured such that, when the pump provides negative pressure through the catheter, fluid is drawn into the one or more drainage ports while mucosal tissue is prevented from appreciably occluding the one or more drainage ports.

10. The negative pressure therapy system of claim 9 , wherein the one or more drainage ports are located on a radially inwardly facing side of the retention portion and, when the pump provides negative pressure through the catheter, a radially outwardly facing side of the retention portion inhibits mucosal tissue from contacting the one or more drainage ports.

11. The negative pressure therapy system of claim 10 , wherein the radially outwardly facing side of the retention portion is essentially free of drainage ports.

12. A negative pressure therapy system for increasing urine production, the negative pressure therapy system comprising:

(a) a pump assembly, the pump assembly comprising:

(i) a pump configured to provide negative pressure to a kidney, and

(ii) a controller configured to regulate the negative pressure of about 5 mm Hg to about 25 mm Hg provided by the pump, based upon changes in physiological condition, so as to increase urine output from the kidney.

13. The negative pressure therapy system of claim 12 , further comprising one or more sensors that detect change(s) in the physiological condition, wherein the controller regulates the negative pressure provided by the pump based upon information measured by the one or more sensors.

14. The negative pressure therapy system of claim 13 , wherein the controller is integrated into the pump.

15. The negative pressure therapy system of claim 13 , wherein the controller is located outside of a body.

16. The negative pressure therapy system of claim 13 , wherein the pump is located outside of a body.

17. The negative pressure therapy system of claim 13 , further comprising a catheter having (i) a proximal portion comprising a drainage lumen and (ii) a distal portion comprising a retention portion configured to be positioned in a urinary tract, the retention portion comprising one or more drainage ports that permit fluid flow into the drainage lumen.

18. The negative pressure therapy system of claim 17 , wherein the proximal portion of the catheter is configured to be connected to the pump to provide negative pressure through the catheter to the kidney.

19. The negative pressure therapy system of claim 18 , wherein the retention portion is configured such that, when the pump provides negative pressure through the catheter, fluid is drawn into the one or more drainage ports while mucosal tissue is prevented from appreciably occluding the one or more drainage ports.

20. The negative pressure therapy system of claim 19 , wherein the one or more drainage ports are located on a radially inwardly facing side of the retention portion and, when the pump provides negative pressure through the catheter, a radially outwardly facing side of the retention portion inhibits mucosal tissue from contacting the one or more drainage ports.

21. The negative pressure therapy system of claim 20 , wherein the radially outwardly facing side of the retention portion is essentially free of drainage ports.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY INTERNAL ADDRESS PREVIOUSLY RECORDED AT REEL: 057647 FRAME: 0601. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 22, 2022
From: STRATACA SYSTEMS, LTD.
To: ROIVIOS LIMITED
Reel/Frame 059279/0434 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2021
From: STRATACA SYSTEMS LTD.
To: ROIVIOS LIMITED
Reel/Frame 057647/0601 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2021
From: ERBEY, JOHN R., II; UPPERCO, JACOB L.; FISHER, MICHAEL ALAN; STRANE, PATRICK WILLIAM; BLACK, LANCE MICHAEL
To: STRATACA SYSTEMS LIMITED
Reel/Frame 057173/0314 →
Continuity (7)
Continuation 16036971 · Jul 17, 2018
Continuation 15214955 · Jul 20, 2016
Provisional Application 62300025 · Feb 25, 2016
Provisional Application 62278721 · Jan 14, 2016
Provisional Application 62260966 · Nov 30, 2015
Provisional Application 62194585 · Jul 20, 2015
Related Publication 20210361908A1 · Nov 25, 2021